PURPOSE: We assessed whether increased cancer screening rates that were observed with Cancer Screening Office Systems (Cancer SOS) could be maintained at 24 months' follow-up, a period in which clinics were expected to be largely self-sufficient in maintaining the intervention. METHODS:Eight primary care clinics serving disadvantaged populations in Hills-borough County, Fla, agreed to take part in a cluster-randomized experimental trial. Charts of independent samples of established patients aged 50 to 75 years were abstracted, with data collected at baseline (n = 1,196) and at 24 months' follow-up (n = 1,296). Papanicolaou (Pap) smears, mammography, and fecal occult blood testing were assessed. RESULTS: At 24 months of follow-up, intervention patients had received a greater number of cancer screening tests (mean 1.17 tests vs 0.94 tests, t test = 4.42, P <.0001). In multivariate analysis that controlled for baseline screening rates, secular trends, and other patient and clinic characteristics, the intervention increased the odds of mammograms slightly (odds ratio [OR]) = 1.26; 95% confidence interval [CI], 1.02-1.55; P = .03) but had no effect on fecal occult blood tests (OR = 1.17; 95% CI, 0.92-1.48; P =0.19) or Pap smears (OR = 0.88; 95% CI, 0.0.68-1.15; P = .34). CONCLUSIONS: The Cancer SOS intervention had persistent, although modest, effects on screening at 24 months' follow-up, an effect that had clearly diminished from results reported at 12 months' follow-up. Further study is needed to develop successful intervention strategies that are either self-sustaining or that are able to produce long-term changes in screening behavior.
RCT Entities:
PURPOSE: We assessed whether increased cancer screening rates that were observed with Cancer Screening Office Systems (Cancer SOS) could be maintained at 24 months' follow-up, a period in which clinics were expected to be largely self-sufficient in maintaining the intervention. METHODS: Eight primary care clinics serving disadvantaged populations in Hills-borough County, Fla, agreed to take part in a cluster-randomized experimental trial. Charts of independent samples of established patients aged 50 to 75 years were abstracted, with data collected at baseline (n = 1,196) and at 24 months' follow-up (n = 1,296). Papanicolaou (Pap) smears, mammography, and fecal occult blood testing were assessed. RESULTS: At 24 months of follow-up, intervention patients had received a greater number of cancer screening tests (mean 1.17 tests vs 0.94 tests, t test = 4.42, P <.0001). In multivariate analysis that controlled for baseline screening rates, secular trends, and other patient and clinic characteristics, the intervention increased the odds of mammograms slightly (odds ratio [OR]) = 1.26; 95% confidence interval [CI], 1.02-1.55; P = .03) but had no effect on fecal occult blood tests (OR = 1.17; 95% CI, 0.92-1.48; P =0.19) or Pap smears (OR = 0.88; 95% CI, 0.0.68-1.15; P = .34). CONCLUSIONS: The Cancer SOS intervention had persistent, although modest, effects on screening at 24 months' follow-up, an effect that had clearly diminished from results reported at 12 months' follow-up. Further study is needed to develop successful intervention strategies that are either self-sustaining or that are able to produce long-term changes in screening behavior.
Authors: J W Eley; H A Hill; V W Chen; D F Austin; M N Wesley; H B Muss; R S Greenberg; R J Coates; P Correa; C K Redmond Journal: JAMA Date: 1994-09-28 Impact factor: 56.272
Authors: R B Burns; E P McCarthy; K M Freund; S L Marwill; M Shwartz; A Ash; M A Moskowitz Journal: Ann Intern Med Date: 1996-08-01 Impact factor: 25.391
Authors: Beverly B Green; Melissa L Anderson; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon Journal: Cancer Date: 2015-10-21 Impact factor: 6.860
Authors: Michael K Dougherty; Alison T Brenner; Seth D Crockett; Shivani Gupta; Stephanie B Wheeler; Manny Coker-Schwimmer; Laura Cubillos; Teri Malo; Daniel S Reuland Journal: JAMA Intern Med Date: 2018-12-01 Impact factor: 21.873
Authors: Muriel Jean-Jacques; Erin O Kaleba; John L Gatta; Gabriela Gracia; Elizabeth R Ryan; Bechara N Choucair Journal: Ann Fam Med Date: 2012 Sep-Oct Impact factor: 5.166
Authors: Shawna V Hudson; Pamela Ohman-Strickland; Regina Cunningham; Jeanne M Ferrante; Karissa Hahn; Benjamin F Crabtree Journal: Cancer Detect Prev Date: 2007-11-26
Authors: Allen J Dietrich; Jonathan N Tobin; Andrea Cassells; Christina M Robinson; Meredith Reh; Karen A Romero; Ann Barry Flood; Michael L Beach Journal: Ann Fam Med Date: 2007 Jul-Aug Impact factor: 5.166